- call +1-201-465-4211
- email sales@mrinsights.biz
Biologic therapeutics drugs are genetically engineered proteins derived from human genetic material. They contain sugars, proteins, nucleic acids, or complex combinations of these substances, or may be living entities such as cells and tissues. In addition, biologics drugs are derived from natural sources such as animals, humans, and microorganisms that are further utilized to make therapeutic products such as vaccines, blood components, and recombinant therapeutic proteins.
Scope of the Report:
This report studies the Biologic Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Biologic Therapeutics market by product type and applications/end industries.
First and foremost, increasing reimbursement for biologics is predicted to positively influence the biologic therapeutics market in the upcoming years. Medical insurance companies and state-run insurance schemes are increasingly accepting claims against biologic therapeutics. Biologic therapeutics are gaining popularity due the efficacy of biologic therapeutic drugs and fewer side effects than chemical-based drugs. This is because biologic drugs are obtained from natural sources such as plants, or even living components such as cells and tissues of animals, microorganisms, or humans. These fragments are further treated to make therapeutic products such as blood components, vaccines, and recombinant therapeutic proteins.
Increasing prevalence of chronic diseases such as cancer, diabetes, and coronary artery diseases and a growing geriatric population are some other factors contributing to the biologic therapeutics market. In addition, mounting clinical trials and innovative research and development practices to develop novel drugs is boosting the growth of biologic therapeutics market.
On the flip side, manufacturing difficulties due to complexities of drug molecules is challenging the growth of biologic therapeutics market. Nevertheless, increasing research and development in the pharmaceutical sector and rising applications of biologics is anticipated to provide new opportunities to this market.
The global Biologic Therapeutics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Biologic Therapeutics.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Pfizer
Novartis Global
AstraZeneca
Merck
GlaxoSmithKline
Aurobindo Pharma
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Vaccines
Blood Products
Allergenic Extracts
Human Cells and Tissues
Gene Therapies
Protein
Cellular Therapies
Xenotransplantation Products
Market Segment by Applications, can be divided into
Rheumatoid Arthritis
Anemia
Cancer
Diabetes
Others
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Biologic Therapeutics Market Overview
1.1 Product Overview and Scope of Biologic Therapeutics
1.2 Classification of Biologic Therapeutics by Types
1.2.1 Global Biologic Therapeutics Revenue Comparison by Types (2017-2023)
1.2.2 Global Biologic Therapeutics Revenue Market Share by Types in 2017
1.2.3 Vaccines
1.2.4 Blood Products
1.2.5 Allergenic Extracts
1.2.6 Human Cells and Tissues
1.2.7 Gene Therapies
1.2.8 Protein
1.2.9 Cellular Therapies
1.2.10 Xenotransplantation Products
1.3 Global Biologic Therapeutics Market by Application
1.3.1 Global Biologic Therapeutics Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Rheumatoid Arthritis
1.3.3 Anemia
1.3.4 Cancer
1.3.5 Diabetes
1.3.6 Others
1.4 Global Biologic Therapeutics Market by Regions
1.4.1 Global Biologic Therapeutics Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Biologic Therapeutics Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Biologic Therapeutics Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Biologic Therapeutics Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Biologic Therapeutics Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Biologic Therapeutics Status and Prospect (2013-2023)
1.5 Global Market Size of Biologic Therapeutics (2013-2023)
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Biologic Therapeutics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Biologic Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.2 Novartis Global
2.2.1 Business Overview
2.2.2 Biologic Therapeutics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novartis Global Biologic Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.3 AstraZeneca
2.3.1 Business Overview
2.3.2 Biologic Therapeutics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 AstraZeneca Biologic Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.4 Merck
2.4.1 Business Overview
2.4.2 Biologic Therapeutics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Merck Biologic Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.5 GlaxoSmithKline
2.5.1 Business Overview
2.5.2 Biologic Therapeutics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 GlaxoSmithKline Biologic Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.6 Aurobindo Pharma
2.6.1 Business Overview
2.6.2 Biologic Therapeutics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Aurobindo Pharma Biologic Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
3 Global Biologic Therapeutics Market Competition, by Players
3.1 Global Biologic Therapeutics Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Biologic Therapeutics Players Market Share
3.2.2 Top 10 Biologic Therapeutics Players Market Share
3.3 Market Competition Trend
4 Global Biologic Therapeutics Market Size by Regions
4.1 Global Biologic Therapeutics Revenue and Market Share by Regions
4.2 North America Biologic Therapeutics Revenue and Growth Rate (2013-2018)
4.3 Europe Biologic Therapeutics Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Biologic Therapeutics Revenue and Growth Rate (2013-2018)
4.5 South America Biologic Therapeutics Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Biologic Therapeutics Revenue and Growth Rate (2013-2018)
5 North America Biologic Therapeutics Revenue by Countries
5.1 North America Biologic Therapeutics Revenue by Countries (2013-2018)
5.2 USA Biologic Therapeutics Revenue and Growth Rate (2013-2018)
5.3 Canada Biologic Therapeutics Revenue and Growth Rate (2013-2018)
5.4 Mexico Biologic Therapeutics Revenue and Growth Rate (2013-2018)
6 Europe Biologic Therapeutics Revenue by Countries
6.1 Europe Biologic Therapeutics Revenue by Countries (2013-2018)
6.2 Germany Biologic Therapeutics Revenue and Growth Rate (2013-2018)
6.3 UK Biologic Therapeutics Revenue and Growth Rate (2013-2018)
6.4 France Biologic Therapeutics Revenue and Growth Rate (2013-2018)
6.5 Russia Biologic Therapeutics Revenue and Growth Rate (2013-2018)
6.6 Italy Biologic Therapeutics Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Biologic Therapeutics Revenue by Countries
7.1 Asia-Pacific Biologic Therapeutics Revenue by Countries (2013-2018)
7.2 China Biologic Therapeutics Revenue and Growth Rate (2013-2018)
7.3 Japan Biologic Therapeutics Revenue and Growth Rate (2013-2018)
7.4 Korea Biologic Therapeutics Revenue and Growth Rate (2013-2018)
7.5 India Biologic Therapeutics Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Biologic Therapeutics Revenue and Growth Rate (2013-2018)
8 South America Biologic Therapeutics Revenue by Countries
8.1 South America Biologic Therapeutics Revenue by Countries (2013-2018)
8.2 Brazil Biologic Therapeutics Revenue and Growth Rate (2013-2018)
8.3 Argentina Biologic Therapeutics Revenue and Growth Rate (2013-2018)
8.4 Colombia Biologic Therapeutics Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Biologic Therapeutics by Countries
9.1 Middle East and Africa Biologic Therapeutics Revenue by Countries (2013-2018)
9.2 Saudi Arabia Biologic Therapeutics Revenue and Growth Rate (2013-2018)
9.3 UAE Biologic Therapeutics Revenue and Growth Rate (2013-2018)
9.4 Egypt Biologic Therapeutics Revenue and Growth Rate (2013-2018)
9.5 Nigeria Biologic Therapeutics Revenue and Growth Rate (2013-2018)
9.6 South Africa Biologic Therapeutics Revenue and Growth Rate (2013-2018)
10 Global Biologic Therapeutics Market Segment by Type
10.1 Global Biologic Therapeutics Revenue and Market Share by Type (2013-2018)
10.2 Global Biologic Therapeutics Market Forecast by Type (2018-2023)
10.3 Vaccines Revenue Growth Rate (2013-2023)
10.4 Blood Products Revenue Growth Rate (2013-2023)
10.5 Allergenic Extracts Revenue Growth Rate (2013-2023)
10.6 Human Cells and Tissues Revenue Growth Rate (2013-2023)
10.7 Gene Therapies Revenue Growth Rate (2013-2023)
10.8 Protein Revenue Growth Rate (2013-2023)
10.9 Cellular Therapies Revenue Growth Rate (2013-2023)
10.10 Xenotransplantation Products Revenue Growth Rate (2013-2023)
11 Global Biologic Therapeutics Market Segment by Application
11.1 Global Biologic Therapeutics Revenue Market Share by Application (2013-2018)
11.2 Biologic Therapeutics Market Forecast by Application (2018-2023)
11.3 Rheumatoid Arthritis Revenue Growth (2013-2018)
11.4 Anemia Revenue Growth (2013-2018)
11.5 Cancer Revenue Growth (2013-2018)
11.6 Diabetes Revenue Growth (2013-2018)
11.7 Others Revenue Growth (2013-2018)
12 Global Biologic Therapeutics Market Size Forecast (2018-2023)
12.1 Global Biologic Therapeutics Market Size Forecast (2018-2023)
12.2 Global Biologic Therapeutics Market Forecast by Regions (2018-2023)
12.3 North America Biologic Therapeutics Revenue Market Forecast (2018-2023)
12.4 Europe Biologic Therapeutics Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Biologic Therapeutics Revenue Market Forecast (2018-2023)
12.6 South America Biologic Therapeutics Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Biologic Therapeutics Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Biologic Therapeutics Picture
Table Product Specifications of Biologic Therapeutics
Table Global Biologic Therapeutics and Revenue (Million USD) Market Split by Prod
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
